Quantum-Si (NASDAQ:QSI) Trading Down 0.5% – Time to Sell?

Quantum-Si Incorporated (NASDAQ:QSI)’s stock price fell 0.5% on Wednesday . The stock traded as low as $0.86 and last traded at $0.8620. 2,249,786 shares traded hands during mid-day trading, a decline of 51% from the average session volume of 4,623,178 shares. The stock had previously closed at $0.8662.

Analyst Ratings Changes

Separately, Weiss Ratings downgraded shares of Quantum-Si from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, July 8th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Reduce” and an average price target of $1.00.

Quantum-Si Trading Down 0.5%

The firm has a market capitalization of $187.71 million, a price-to-earnings ratio of -1.69 and a beta of 3.20. The company’s 50 day moving average is $0.97 and its 200-day moving average is $0.99.

Quantum-Si (NASDAQ:QSI) last announced its quarterly earnings results on Thursday, May 7th. The company reported ($0.10) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.02. The firm had revenue of $0.26 million for the quarter, compared to the consensus estimate of $0.30 million. Quantum-Si had a negative return on equity of 47.35% and a negative net margin of 5,605.88%. Research analysts expect that Quantum-Si Incorporated will post -0.49 EPS for the current year.

Insiders Place Their Bets

In other Quantum-Si news, CEO Jeffrey Alan Hawkins sold 83,712 shares of the company’s stock in a transaction on Monday, April 20th. The shares were sold at an average price of $1.01, for a total value of $84,549.12. Following the transaction, the chief executive officer directly owned 3,776,135 shares in the company, valued at $3,813,896.35. The trade was a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Jeffry R. Keyes sold 37,381 shares of the company’s stock in a transaction on Tuesday, April 21st. The shares were sold at an average price of $0.99, for a total transaction of $37,007.19. Following the completion of the transaction, the chief financial officer owned 1,732,582 shares in the company, valued at approximately $1,715,256.18. This represents a 2.11% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 219,552 shares of company stock worth $216,114. 22.04% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. JPMorgan Chase & Co. grew its position in shares of Quantum-Si by 15.6% during the 2nd quarter. JPMorgan Chase & Co. now owns 66,656 shares of the company’s stock worth $131,000 after purchasing an additional 9,005 shares in the last quarter. The Manufacturers Life Insurance Company raised its position in shares of Quantum-Si by 27.4% in the second quarter. The Manufacturers Life Insurance Company now owns 49,082 shares of the company’s stock valued at $96,000 after buying an additional 10,564 shares in the last quarter. Prudential Financial Inc. bought a new stake in shares of Quantum-Si in the second quarter valued at approximately $25,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Quantum-Si by 23.8% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 70,552 shares of the company’s stock valued at $85,000 after buying an additional 13,546 shares during the period. Finally, Cerity Partners LLC bought a new stake in shares of Quantum-Si in the second quarter valued at approximately $29,000. Institutional investors and hedge funds own 39.90% of the company’s stock.

Quantum-Si Company Profile

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.